Skip to main content

Home/ medindia/ Group items tagged as

Rss Feed Group items tagged

Filter: All | Bookmarks | Topics Simple Middle
med india

Cancer Fighting "Super Broccoli" in UK Markets - 0 views

www.medindia.net/...coli-in-UK-Markets-91666-1.htm

super broccoli anti-oxidant Vitamin C foods prostate cancer health food heart diseases stroke vegetables cabbage family dietary fiber beneforte glucoraphanin Mark and Spencer sulphoraphane natural treatment UK

shared by med india on 08 Oct 11 - No Cached
  • med india on 08 Oct 11
     
    Broccoli is a vegetable that belongs to the same cruciferous family as the cabbage, cauliflower, brussel sprouts. Abundantly endowed with Vitamin C, anti-oxidants, and fiber, broccoli is known to have several health benefits and is classified as one among the world's top ten superfoods!
med india

Patient Data Makes Its Way on Facebook | MedIndia - 0 views

www.medindia.net/...ts-Way-on-Facebook-92646-1.htm

patients records NHS breach daily health news for the day dental pharma medical breakthroughs topic

shared by med india on 29 Oct 11 - No Cached
  • med india on 29 Oct 11
     
    It may come as a shock to many readers about the extent of breach of patient records, as recently, personal details and a photograph of a patient have been posted on Facebook by the NHS.
kyra smith

Clinical Trial Services - 0 views

www.worksure.org/clinical-trial-services

medical

shared by kyra smith on 16 Jan 17 - No Cached
  • kyra smith on 16 Jan 17
     
    Developing a new medicine is a sophisticated and complex task which initially begins with the understanding of disease or condition as thoroughly as possible. At first, the researchers conduct studies in cells, tissues and animal models to determine whether the disease or condition can be influenced by new molecule.
med india

A-Z Health Topics - 0 views

www.medindia.net/...index_e.htm

Eating Disorder Ear Blockage (Wax Blockage) Eclampsia Ectopic Pregnancy Egg Donation Endometrial Cancer Enuresis Epigenetics Epilepsy Epistaxis.

shared by med india on 27 Apr 12 - No Cached
  • med india on 27 Apr 12
     
    An interesting reference guide of medical disorders - provided as an A-Z listing for quick and easy reference. Includes topics like Cystic Fibrosis, Hydatid disease, Skin Disorder, Atopic Dermatitis, Atopic Dermatitis.
med india

Brain-damaged Patients in Vegetative State Respond to EEG Scan: Study | MedIndia - 0 views

www.medindia.net/...-to-EEG-Scan-Study-93170-1.htm

EEG brain damaged coma vegetative state daily health news for the day dental pharma medical breakthroughs topic

shared by med india on 10 Nov 11 - No Cached
  • med india on 10 Nov 11
     
    Electro-encephalography (EEG) enlightened doctors that several patients diagnosed as being in a permanently vegetative state were in fact aware.
Alex Parker

Dainippon's Latuda gets approval in Canada to treat bipolar depression - 1 views

regulatoryaffairs.pharmaceutical-business-review.com/...olar-depression-040414-4209058

health news medical pharma

shared by Alex Parker on 04 Apr 14 - No Cached
  • Alex Parker on 04 Apr 14
     
    Dainippon Sumitomo Pharma (DSP) has received approval from Health Canada for use of Latuda (lurasidone HCl) as monotherapy or as adjunctive therapy with lithium or valproate to treat depressive episodes associated with bipolar I disorder.
Alex Parker

KYTHERA files NDA for ATX-101 to reduce unwanted submental fat - 1 views

drugdelivery.pharmaceutical-business-review.com/...d-submental-fat-130514-4265243

health news medical pharma

shared by Alex Parker on 13 May 14 - No Cached
  • Alex Parker on 13 May 14
     
    US-based KYTHERA Biopharmaceuticals has submitted a new drug application (NDA) to the US Food and Drug Administration (FDA) for ATX-101 (deoxycholic acid) as an injectable treatment for the reduction of submental fat, which commonly presents as a double chin.
Hellan George

How a pharmaceutical market researcher is frustrated? - 0 views

whybenchmarking.com/...armaceutical-market-researcher

pharmaceutical market researcher medical frustrated best practices

shared by Hellan George on 28 Aug 15 - No Cached
  • Hellan George on 28 Aug 15
     
    Not that long ago, I was updating a key research project here at Best Practices; and as usual, I was waiting on approval from our research manager...
med india

Physical Activity Reduces Mortality in People With Metabolic Syndrome | MedIndia - 0 views

www.medindia.net/...Metabolic-Syndrome-91796-1.htm

physical activity and mortality heart disease stroke diabetes diet exercise metabolic syndrome death regular weight loss. daily health news for the day dental pharma medical breakthroughs topic

shared by med india on 11 Oct 11 - No Cached
  • med india on 11 Oct 11
     
    Metabolic syndrome is a term used for a group of risk factors that, if present together in a person, increase the risk of heart disease, stroke and diabetes. It is also known as Syndrome X or Insulin Resistance Syndrome.
med india

Healthy Childhood Diet may Lower Chronic Disease Risk | MedIndia - 0 views

www.medindia.net/...ronic-Disease-Risk-92766-1.htm

childhood diet diabetes heart diseases children metabolic syndrome fat content fiber daily health news for the day dental pharma medical breakthroughs topic

shared by med india on 01 Nov 11 - No Cached
  • med india on 01 Nov 11
     
    Childhood diet lower in fat and higher in fiber content can decrease risk for chronic diseases such as diabetes and heart disease in adulthood, shows study.
med india

Breast Lumps in Women - Symptom Evaluation - 0 views

www.medindia.net/...n-women-symptom-evaluation.htm

mammary glands cancer-related deaths breast lumps biopsy benign symptoms of cancer mastitis lump screening self exam Causes breastCysts women fibroadenomas pseudolumps menstrual cycle hormonal tissue monthly periods pregnancy infections injuries painless

shared by med india on 29 Oct 11 - No Cached
  • med india on 29 Oct 11
     
    Breast changes, such as lumps are common in women. Keeping the threat of breast cancer in mind every lump should be medically evaluated.
indiacancercare

The Price of Hope: Understanding the Cost of Kidney Cancer Treatment in India - 0 views

steemit.com/...dney-cancer-treatment-in-india

Kidney Cancer Surgery in India Cost of Kidney Cancer Treatment India Affordable Cost of Kidney Cancer Treatment India Top Kidney Cancer Hospitals of India Top 10 kidney cancer doctors of india

shared by indiacancercare on 17 Mar 23 - No Cached
  • indiacancercare on 17 Mar 23
     
    Cost of kidney cancer treatment India is surprisingly affordable as compared to another country globally and the presence of noticeably experienced doctors and surgeons.
Doughlas David

One Step Closer To Your Dreams - 1 views

The trains and railways provide speed and ease to travelling passengers. I love trains and that motivates me to Become a train driver. I really want to drive a train myself. I want to take every ...

Become a train driver

started by Doughlas David on 01 Mar 12 no follow-up yet
Alex Parker

OctreoPharm's OPS202 gets EMA orphan drug designation for management of GEP-NETs - 0 views

regulatoryaffairs.pharmaceutical-business-review.com/...manage-gep-nets-300114-4168590

health medical news

shared by Alex Parker on 31 Jan 14 - No Cached
  • Alex Parker on 31 Jan 14
     
    Germany-based OctreoPharm Sciences has received Orphan Drug Designation from the European Medicines Agency (EMA) for OPS202 as a diagnostic agent for the management of patients with gastro-entero-pancreatic-neuroendocrine tumors
Alex Parker

Bristol-Myers Squibb gets FDA breakthrough designation for daclatasvir-based regimen - 0 views

regulatoryaffairs.pharmaceutical-business-review.com/...r-based-regimen-250214-4183423

health medical news pharma breakthroughs

shared by Alex Parker on 25 Feb 14 - No Cached
  • Alex Parker on 25 Feb 14
     
    PBR Staff Writer Published 25 February 2014 Bristol-Myers Squibb (BMS) has received Breakthrough Therapy Designation from the US Food and Drug Administration (FDA) for its investigational DCV Dual Regimen (daclatasvir and asunaprevir) for use as a combination therapy in the treatment of genotype 1b chronic hepatitis C infection (HCV).
Alex Parker

Novartis reshapes business by signing deals with GSK, Eli Lilly - 2 views

manufacturing.pharmaceutical-business-review.com/...h-gsk-eli-lilly-220414-4218360

health news medical pharma daily

shared by Alex Parker on 23 Apr 14 - No Cached
  • Alex Parker on 23 Apr 14
     
    PBR Staff Writer Published 22 April 2014 Swiss pharmaceutical firm Novartis has entered into a definitive agreement to acquire the oncology unit of Britain's GlaxoSmithKline (GSK) for about $14.5bn and up to $1.5bn contingent on a development milestone. As part of the deal, Novartis would have opt-in rights to GSK's current and future oncology R&D pipeline.
Alex Parker

FDA approves GSK's Incruse Ellipta to treat airflow obstruction in COPD patients - 1 views

regulatoryaffairs.pharmaceutical-business-review.com/...n-copd-patients-010514-4256177

health news medical pharma daily

shared by Alex Parker on 01 May 14 - No Cached
  • Alex Parker on 01 May 14
     
    PBR Staff Writer Published 01 May 2014 The US Food and Drug Administration (FDA) has approved GlaxoSmithKline's (GSK) Incruse Ellipta (umeclidinium) for the treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. Umeclidinium is a once-daily long-acting muscarinic antagonist (LAMA), a type of bronchodilator also known as an anticholinergic.
Alex Parker

GlaxoSmithKline's once-weekly diabetes drug Eperzan gets marketing approval in Europe - 1 views

drugdelivery.pharmaceutical-business-review.com/...roval-in-europe-270314-4204343

health news medical pharma

shared by Alex Parker on 27 Mar 14 - No Cached
  • Alex Parker on 27 Mar 14
     
    PBR Staff Writer Published 27 March 2014 The European Commission (EC) has granted marketing authorization for GlaxoSmithKline's (GSK's) once-weekly diabetes treatment, Eperzan (albiglutide). The drug is indicated for the treatment of type 2 diabetes mellitus in adults, to improve glucose control as monotherapy, when diet and exercise alone do not provide adequate glycaemic control in patients for whom the use of metformin is considered inappropriate due to contraindications or intolerance.
Alex Parker

ESMO 2019: Seven promising liquid biopsy companies at the conference - 1 views

www.medicaldevice-network.com/...o-2019-liquid-biopsy-companies

health news medical pharma

shared by Alex Parker on 27 Sep 19 - No Cached
  • Alex Parker on 27 Sep 19
     
    Research and development (R&D) in liquid biopsy is increasingly being funded by both public and private sectors due to its promising features such as early detection of cancer tumour, new lesion characterisation and identification of cancer drug target.
1 - 20 of 20
Showing 20▼ items per page